Literature DB >> 6315423

The potential uses of ceftriaxone.

W M Scheld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6315423     DOI： 10.1007/bf02013913

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  36 in total

1.  Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.

Authors:  R W Steele; L B Eyre; R W Bradsher; R E Weinfeld; I H Patel; J Spicehandler
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

2.  Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.

Authors:  M Seddon; R Wise; A P Gillett; R Livingston
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

3.  In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins.

Authors:  S Shelton; J D Nelson; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

4.  [Bacteriological, pharmacological and clinical comparison between amoxycillin and ceftriaxone in the treatment of 300 purulent meningitis ].

Authors:  M Cadoz; F Denis; T Guerma; M Prince-David; I Diop Mar
Journal:  Pathol Biol (Paris)       Date:  1982-06

5.  Single-dose pharmacokinetics of ceftriaxone in infants and young children.

Authors:  U B Schaad; K Stoeckel
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

6.  In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases.

Authors:  K Shannon; A King; C Warren; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

7.  Dose-ranging study of ceftriaxone for uncomplicated gonorrhea in men.

Authors:  H H Handsfield; V L Murphy; K K Holmes
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

8.  Ceftriaxone therapy of serious bacterial infections.

Authors:  L J Eron; C H Park; R I Goldenberg; D M Poretz
Journal:  J Antimicrob Chemother       Date:  1983-07       Impact factor: 5.790

9.  Comparison of susceptibilities of anaerobic bacteria to cefmenoxime, ceftriaxone, and other antimicrobial compounds.

Authors:  H M Pollock; J Holt; C Murray
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

10.  Comparative study of ceftriaxone and aqueous procaine penicillin G in the treatment of uncomplicated gonorrhea in women.

Authors:  F N Judson; J M Ehret; C J Root
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191
View more
  1 in total

1.  Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis.

Authors:  J P Bryan; H Rocha; H R da Silva; A Taveres; M A Sande; W M Scheld
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.